Urologic Oncology: Seminars and Original Investigations
Volume 27, Issue 1 , Pages 72-74, January 2009

Optimizing outcomes at every stage of bladder cancer: Do we practice it?

Department of Urology, University of Michigan, Ann Arbor, MI 48109, USA

Abstract 

Defining the best practices in treating any disease can lead to optimal treatment. Establishing these best practices is difficult, and relies on clinical trials, expert opinion, and consensus decisions. Bladder cancer is a heterogeneous disease that can be either relatively benign or highly malignant depending on the grade and stage of the tumor. Determining the best practices for bladder cancer is based on the stage, grade, and presentation of the cancer. Herein we identify four clinical scenarios involving bladder cancer and discuss whether best practice guidelines are available for these clinical scenarios, and if so, how often do we follow these guidelines.

Keywords: Bladder cancer, Treatment, Outcomes

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1078-1439(08)00152-X

doi:10.1016/j.urolonc.2008.06.005

Urologic Oncology: Seminars and Original Investigations
Volume 27, Issue 1 , Pages 72-74, January 2009

Article Tools